Scientists Reveal What Happens to Your Body When You Drink Coffee Every Day
We asked experts to explain how the morning delicacy can have such an impact.
There are a few catches.
The ritual of brewing and sipping fresh coffee each morning is one many of us look forward to, and a new study's findings may give you the push to pour another cup. Researchers connected coffee consumption to mortality among a large population of participants and found that coffee may actually help you live longer, with a few caveats.
Meet the Experts: David Perlmutter, M.D., a neurologist and fellow of the American College of Nutrition and Michelle Routhenstein, M.S., R.D., a cardiology dietitian at Entirely Nourished.
Keep reading to learn more about how your daily cup of joe may offer you more than a jolt of energy and happiness.
Researchers tracked the self-reported coffee drinking habits of over 46,000 U.S. adults for nearly a decade. Participants disclosed how they drank their java. Regular or decaf? With sugar and milk or without? If with, how much? They then compared that information to National Death Index data to deduce how coffee consumption could have impacted mortality from all causes, including cancer and heart disease.
After examining the data, researchers found that drinking one to three cups of coffee per day was linked to a reduced risk of death from all causes, 'especially when the coffee is black or has minimal added sugar and saturated fat,' explains David Perlmutter, M.D., a neurologist and fellow of the American College of Nutrition. Specifically, they found that drinking black coffee or coffee with less than 2.5 grams (or a little more than a half-teaspoon) of sugar and less than a gram of saturated fat from milk or cream per 8-ounce cup was associated with a 14% lower risk of dying from any cause compared to not drinking coffee at all, Dr. Perlmutter adds.
The catch here is, the study also found that most Americans add around 3.2 grams of sugar and a half-gram of saturated fat to each mug, which means the majority of coffee drinkers are less likely to get its life-extending benefits. 'This is the problem with so many coffee specialty drinks that seem to be so popular,' Dr. Perlmutter says.
There is plenty of existing research that purports coffee's health boost. Without added sugar or fat, it's a naturally good source of antioxidants like polyphenols and chlorogenic acid, explains Dr. Purlmutter. 'These components and others help fight inflammation and oxidative stress,' he adds, both of which are contributors to chronic disease. That's how coffee may help reduce risk of type 2 diabetes, cardiovascular disease, and congnitive decline, 'all of which influence lifespan,' he concludes.
Coffee's caffeine content can even exhibit perks by improving alertness, metabolism, and brain health, Dr. Pelrmutter says. However, there is such a thing as overdoing it and reaping negative side-effects such as anxiety, increased blood pressure, heart palpitations, digestive issues, and insomnia, says Michelle Routhenstein, M.S., R.D., a cardiology dietitian at Entirely Nourished.
She adds that a 'very high coffee intake may also slightly reduce calcium absorption, potentially affecting bone health.'
The study supports drinking one to three cups of black or minimally altered coffee per day. Dr. Perlmutter recommends keeping sugars below 2.5 grams and saturated fats below 1 gram per cup by using low-fat milk or plant-based creamer alternatives. Routhenstein adds that if you are pregnant or breastfeeding, or have otherwise been prescribed a specific caffeine intake, follow your doctor's recommendations.
Lastly, to avoid over-caffeination, Dr. Perlmutter suggests enforcing a 'coffee curfew' that marks the time of day after which you turn off the pot. 'I generally recommend 2 p.m. to minimize coffee's impact on sleep,' he concludes.
You Might Also Like
Can Apple Cider Vinegar Lead to Weight Loss?
Bobbi Brown Shares Her Top Face-Transforming Makeup Tips for Women Over 50
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
11 minutes ago
- Yahoo
FDA Approved Thermo Fisher Scientific's (TMO) Oncomine Dx Express Test
Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the . On July 3, Thermo Fisher Scientific Inc. (NYSE:TMO) announced receiving FDA approval for its Oncomine Dx Express Test on the Ion Torrent Genexus Dx Integrated Sequencer. After the approval, this test is now authorized as an in vitro diagnostic and as a companion diagnostic for Dizal's ZEGFROVY. ZEGFROVY is a targeted therapy for non-small cell lung cancer patients with EGFR exon 20 insertion mutations. The test is also approved for broader tumor profiling in solid tumors, detecting mutations across 46 genes with clinical or potential clinical significance. A workstation in a research lab stocked with laboratory products and services. This is a significant achievement as it brings rapid next-generation sequencing closer to patients. The technology can deliver crucial genomic results in as little as 24 hours. This speed is important for cancer care, as delays in obtaining tumor profiles can prevent patients from receiving timely treatments. Thermo Fisher Scientific Inc. (NYSE:TMO) is a healthcare company that is focused on accelerating research, solving complex analytical problems, boosting laboratory efficiency, and improving patient health. While we acknowledge the potential of TMO as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.
Yahoo
21 minutes ago
- Yahoo
Wells Fargo Maintained a Buy Rating on Elevance Health (ELV), Kept the PT Unchanged
Elevance Health, Inc. (NYSE:ELV) is one of the 11 Best 52-Week Low Stocks to Buy Right Now. On June 18, Wells Fargo analyst Stephen Baxter maintained a Buy rating on Elevance Health, Inc. (NYSE:ELV) with a price target of $478. The bullish sentiment came after the company exceeded analyst expectations in the fiscal first quarter of 2025, despite industry challenges. Elevance Health, Inc. (NYSE:ELV) delivered an operating revenue of $48.8 billion, up 15.4% from Q1 2024, and ahead of expectations by $2.52 billion. The EPS of $11.97 also topped the analyst target by $0.49. This was driven by an increased number of Medical Members, which grew to 45.8 million, up 90,000 since year-end. Management attributed this growth to targeted expansion and strong retention in Medicare Advantage. A medical professional working at a computer, utilizing the company's digital solutions to improve care quality for consumers. In addition, the Individual ACA membership grew about 11% sequentially, but a slowdown is expected in Q2 as some renewals are below expectations. Elevance Health, Inc. (NYSE:ELV) was expecting the first half earnings to account for between 62% to 63% of the full year results. However, due to the slowdown in Individual ACA memberships, it now expects the first half to account for only 60%. Elevance Health, Inc. (NYSE:ELV) is a health company in the United States, known as a major health insurer. The company aims to improve the health of individuals and communities through an integrated, whole-health approach that addresses physical, behavioral, and social needs. While we acknowledge the potential of ELV as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21 minutes ago
- Yahoo
The dangerous anti-abortion victory buried in Trump's megabill
The Atlantic called the president's 'One Big Beautiful Bill Act' the biggest anti-abortion victory since Roe v. Wade was overturned. That's because the mega-bill includes a provision that will bar Planned Parenthood from receiving Medicaid reimbursements – not just for abortion but for any health service they provide. Michele Goodwin, Professor of Constitutional Law & Global Health Policy at Georgetown Law is among the many experts warning that this defunding will have a devastating impact on reproductive healthcare, saying in many of the communities served by Planned Parenthood, 'there's no other place for [patients] to go. There's no other clinic, there's no other county provider, and we are talking about basic health care, like getting vaccinated or even getting prenatal care and postnatal care.' Amanda Zurawski, a reproductive rights activist who nearly died after being denied an abortion under Texas' ban, says stories like hers used to be shocking but are becoming so commonplace, as access to reproductive care is rolled back, that no one notices them anymore. 'We're seeing [lawmakers] coordinate these orchestrated efforts to restrict access, you know, in more sinister and unfortunately creative ways, and it's working. And I think we have to really stay vigilant, and we have to keep an eye on our elected officials,' Zurawski says.